{"id":"NCT03818737","sponsor":"Emory University","briefTitle":"Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)","officialTitle":"Randomized Multicenter Phase 3 Single-blind Trial Comparing the Efficacy of Corticosteroid Control to Mesenchymal Stem Cell Preparations From Autologous Bone Marrow Concentrate (BMAC), Adipose-derived Stem Cells in the Form of Stromal Vascular Fraction (SVF), and Third-party Human Mesenchymal Stem Cells Manufactured From Umbilical Cord Tissue for the Treatment of Unilateral Knee Osteoarthritis (OA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-28","primaryCompletion":"2022-05-31","completion":"2022-05-31","firstPosted":"2019-01-28","resultsPosted":"2023-07-27","lastUpdate":"2023-07-27"},"enrollment":475,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis"],"interventions":[{"type":"BIOLOGICAL","name":"Bone Marrow Derived MSCs","otherNames":[]},{"type":"BIOLOGICAL","name":"Adipose-derived MSCs","otherNames":[]},{"type":"BIOLOGICAL","name":"Umbilical Cord Tissue (UCT) MSCs","otherNames":[]},{"type":"DRUG","name":"Corticosteroid injection","otherNames":["Depo-Medrol","Methylprednisolone"]}],"arms":[{"label":"Bone Marrow Derived MSCs","type":"EXPERIMENTAL"},{"label":"Adipose-derived MSCs","type":"EXPERIMENTAL"},{"label":"Umbilical Cord Tissue (UCT) MSCs","type":"EXPERIMENTAL"},{"label":"Corticosteroid Injection","type":"ACTIVE_COMPARATOR"}],"summary":"The study is a multicenter trial conducted to compare the effectiveness of an injection of a corticosteroid control to mesenchymal stem cell (MSC) preparations from autologous bone marrow concentrate (BMAC), adipose derived stem cells in the form of Stromal Vascular Fraction (SVF), and third-party human mesenchymal stem cells manufactured from umbilical cord tissue (UCT) for the treatment of unilateral Knee Osteoarthritis (OA). The study will be conducted in 4 sites in the United States, and a total of 480 participants will be enrolled in this study.","primaryOutcome":{"measure":"Change in Visual Analog Pain Scale (VAS-pain) Score","timeFrame":"Baseline, 1 month, 3 months, 6 months, 9 months, 12 months","effectByArm":[{"arm":"Bone Marrow Derived MSCs","deltaMin":-20.2,"sd":2.52},{"arm":"Adipose-derived MSCs","deltaMin":-15.9,"sd":2.48},{"arm":"Umbilical Cord Tissue (UCT) MSCs","deltaMin":-16.7,"sd":2.4},{"arm":"Corticosteroid Injection","deltaMin":-25.2,"sd":2.49}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":25},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":["37919438"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":107},"commonTop":["Arthralgia","Procedural pain","Post procedural contusion","Joint swelling","Joint stiffness"]}}